Comparison of long-term results between radiotherapy after breast-conserving surgery and postmastectomy radiotherapy in stage T1-2N1M0 breast cancer

References

• Recht A, Comen EA, Fine RE, et al. Postmastectomy radiotherapy: an American Society of Clinical Oncology, American society for radiation oncology, and society of surgical oncology focused guideline update. J Clin Oncol. 2016;34(36):4431–4442. doi:10.1200/JCO.2016.69.118827646947
   PubMed Web of Science ®Google Scholar
• Gradishar WJ, Anderson BO, Balassanian R, et al. Breast cancer, version 4.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2018;16(3):310–320. doi:10.6004/jnccn.2018.001229523670
   PubMed Web of Science ®Google Scholar
• Poortmans PM, Struikmans H, Bartelink H. Regional nodal irradiation in early-stage breast cancer. N Engl J Med. 2015;373(19):1879–1880. doi:10.1056/NEJMc151050526543931
   PubMedGoogle Scholar
• Poortmans PM, Collette S, Kirkove C, et al. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med. 2015;373(4):317–327. doi:10.1056/NEJMoa141536926200978
   PubMed Web of Science ®Google Scholar
• McGale P, Taylor C, Correa C, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383(9935):2127–2135. doi:10.1016/S0140-6736(14)60488-824656685
   PubMed Web of Science ®Google Scholar
• Goodman CR, Seagle BL, Friedl T, et al. Association of circulating tumor cell status with benefit of radiotherapy and survival in early-stage breast cancer. Jama Oncol. 2018;4(8):e180163. doi:10.1001/jamaoncol.2017.447329800954
   PubMed Web of Science ®Google Scholar
• NIH Consensus Development. Conference statement on the treatment of early-stage breast cancer. Oncology (Williston Park). 1991;5(2):120–124.1826204
   PubMedGoogle Scholar
• Lazovich D, Solomon CC, Thomas DB, Moe RE, White E. Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus development conference on the treatment of patients with early stage invasive breast carcinoma. Cancer Am Cancer Soc. 1999;86(4):628–637.
   Google Scholar
• McGuire KP, Santillan AA, Kaur P, et al. Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol. 2009;16(10):2682–2690. doi:10.1245/s10434-009-0635-x19653046
   PubMed Web of Science ®Google Scholar
• Lee MC, Rogers K, Griffith K, et al. Determinants of breast conservation rates: reasons for mastectomy at a comprehensive cancer center. Breast J. 2009;15(1):34–40. doi:10.1111/j.1524-4741.2008.00668.x19141132
   PubMed Web of Science ®Google Scholar
• Agarwal S, Pappas L, Neumayer L, Kokeny K, Agarwal J. Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer. JAMA Surg. 2014;149(3):267–274. doi:10.1001/jamasurg.2013.304924429935
   PubMed Web of Science ®Google Scholar
• Hofvind S, Holen A, Aas T, Roman M, Sebuodegard S, Akslen LA. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics. Eur J Surg Oncol. 2015;41(10):1417–1422. doi:10.1016/j.ejso.2015.07.00226253193
   PubMed Web of Science ®Google Scholar
• Fisher S, Gao H, Yasui Y, Dabbs K, Winget M. Survival in stage I-III breast cancer patients by surgical treatment in a publicly funded health care system. Ann Oncol. 2015;26(6):1161–1169. doi:10.1093/annonc/mdv10725712459
   PubMed Web of Science ®Google Scholar
• Hartmann-Johnsen OJ, Karesen R, Schlichting E, Nygard JF. Survival is better after breast conserving therapy than mastectomy for early stage breast cancer: a registry-based follow-up study of Norwegian Women primary operated between 1998 and 2008. Ann Surg Oncol. 2015;22(12):3836–3845. doi:10.1245/s10434-015-4441-325743325
   PubMed Web of Science ®Google Scholar
• van Maaren MC, de Munck L, de Bock GH, et al. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study. Lancet Oncol. 2016;17(8):1158–1170. doi:10.1016/S1470-2045(16)30067-527344114
   PubMed Web of Science ®Google Scholar
• Hartmann-Johnsen OJ, Karesen R, Schlichting E, Nygard JF. Better survival after breast-conserving therapy compared to mastectomy when axillary node status is positive in early-stage breast cancer: a registry-based follow-up study of 6387 Norwegian women participating in screening, primarily operated between 1998 and 2009. World J Surg Oncol. 2017;15(1):118.28673296
   PubMedGoogle Scholar
• Edge SB, Compton CC. The American joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471–1474. doi:10.1245/s10434-010-0985-420180029
   PubMed Web of Science ®Google Scholar
• Sobin LH, Compton CC. TNM seventh edition: what’s new, what’s changed: communication from the International Union against cancer and the American joint committee on cancer. Cancer Am Cancer Soc. 2010;116(22):5336–5339.
   Google Scholar
• D’Agostino RJ. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17(19):2265–2281.9802183
   PubMed Web of Science ®Google Scholar
• Austin PC. The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments. Stat Med. 2014;33(7):1242–1258. doi:10.1002/sim.598424122911
   PubMed Web of Science ®Google Scholar
• Taghian A, Jeong JH, Mamounas E, et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National surgical adjuvant breast and bowel project randomized clinical trials. J Clin Oncol. 2004;22(21):4247–4254. doi:10.1200/JCO.2004.01.04215452182
   PubMed Web of Science ®Google Scholar
• Tendulkar RD, Rehman S, Shukla ME, et al. Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy. Int J Radiat Oncol Biol Phys. 2012;83(5):e577–e581. doi:10.1016/j.ijrobp.2012.01.07622560546
   PubMed Web of Science ®Google Scholar
• Huang CJ, Hou MF, Chuang HY, et al. Comparison of clinical outcome of breast cancer patients with T1-2 tumor and one to three positive nodes with or without postmastectomy radiation therapy. Jpn J Clin Oncol. 2012;42(8):711–720. doi:10.1093/jjco/hys08022645150
   PubMed Web of Science ®Google Scholar
• McBride A, Allen P, Woodward W, et al. Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment. Int J Radiat Oncol Biol Phys. 2014;89(2):392–398. doi:10.1016/j.ijrobp.2014.02.01324721590
   PubMed Web of Science ®Google Scholar
• Lai SF, Chen YH, Kuo WH, et al. Locoregional recurrence risk for postmastectomy breast cancer patients with T1-2 and one to three positive lymph nodes receiving modern systemic treatment without radiotherapy. Ann Surg Oncol. 2016;23(12):3860–3869. doi:10.1245/s10434-016-5435-527436202
   PubMed Web of Science ®Google Scholar
• Buus R, Sestak I, Kronenwett R, et al. Comparison of endopredict and EPclin with oncotype DX recurrence score for prediction of risk of distant recurrence after endocrine therapy. J Natl Cancer Inst. 2016;108(11). doi:10.1093/jnci/djw149.
   PubMedGoogle Scholar
• Cheng SH, Horng CF, Huang TT, et al. An eighteen-gene classifier predicts locoregional recurrence in post-mastectomy breast cancer patients. EBioMedicine. 2016;5:74–81. doi:10.1016/j.ebiom.2016.02.02227077114
   PubMed Web of Science ®Google Scholar
• Cheng SH, Huang TT, Cheng YH, et al. Validation of the 18-gene classifier as a prognostic biomarker of distant metastasis in breast cancer. PLoS One. 2017;12(9):e184372. doi:10.1371/journal.pone.0184372
   Web of Science ®Google Scholar
• Darby S, McGale P, Correa C, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378(9804):1707–1716. doi:10.1016/S0140-6736(11)61629-222019144
   PubMed Web of Science ®Google Scholar
• Bernstein MB, Krishnan S, Hodge JW, Chang JY. Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach? Nat Rev Clin Oncol. 2016;13(8):516–524. doi:10.1038/nrclinonc.2016.3026951040
   PubMed Web of Science ®Google Scholar
• Postow MA, Callahan MK, Barker CA, et al. Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med. 2012;366(10):925–931. doi:10.1056/NEJMoa111282422397654
   PubMed Web of Science ®Google Scholar
• Golden EB, Demaria S, Schiff PB, Chachoua A, Formenti SC. An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer. Cancer Immunol Res. 2013;1(6):365–372. doi:10.1158/2326-6066.CIR-13-011524563870
   PubMed Web of Science ®Google Scholar
• Stamell EF, Wolchok JD, Gnjatic S, Lee NY, Brownell I. The abscopal effect associated with a systemic anti-melanoma immune response. Int J Radiat Oncol Biol Phys. 2013;85(2):293–295. doi:10.1016/j.ijrobp.2012.03.01722560555
   PubMed Web of Science ®Google Scholar
• Su S, Chen J, Yao H, et al. CD10(+)GPR77(+) Cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness. Cell. 2018;172(4):841–856. doi:10.1016/j.cell.2018.01.00929395328
   PubMed Web of Science ®Google Scholar
• Su S, Zhao J, Xing Y, et al. Immune checkpoint inhibition overcomes ADCP-Induced Immunosuppression by macrophages. Cell. 2018;175(2):442–457. doi:10.1016/j.cell.2018.09.00730290143
   PubMed Web of Science ®Google Scholar